Sangamo BioSciences | SGMO - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Alaunos Therapeutics USD 400K 213K 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amgen USD 19.52B 1.37B 2026-03
Bayer EUR 6.59B 496M 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cipla INR 32.3B 1.95B 2026-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Grifols EUR 987.75M 47.87M 2025-12
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
J&J USD 10.46B 1.53B 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Merck USD 3.86B 541M 2026-03
Novartis USD 4.32B 134M 2026-03
Omeros USD 8.84M 4.42M 2025-06
Pfizer USD 4.51B 734M 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03